FR2208650A2 - 4'-aminomethyl-spiro(dibenzo(a,d)cycloheptadi(or tri) - ene-5,2' -(1,3)dioxolan)- antidepressants,analgesics,antiinflammatory - Google Patents

4'-aminomethyl-spiro(dibenzo(a,d)cycloheptadi(or tri) - ene-5,2' -(1,3)dioxolan)- antidepressants,analgesics,antiinflammatory

Info

Publication number
FR2208650A2
FR2208650A2 FR7242867A FR7242867A FR2208650A2 FR 2208650 A2 FR2208650 A2 FR 2208650A2 FR 7242867 A FR7242867 A FR 7242867A FR 7242867 A FR7242867 A FR 7242867A FR 2208650 A2 FR2208650 A2 FR 2208650A2
Authority
FR
France
Prior art keywords
cycloheptadi
dioxolan
dibenzo
antidepressants
antiinflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7242867A
Other languages
English (en)
French (fr)
Other versions
FR2208650B2 (cs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE793611D priority Critical patent/BE793611A/xx
Application filed by Delalande SA filed Critical Delalande SA
Priority to FR7242867A priority patent/FR2208650A2/fr
Priority to ZA730009A priority patent/ZA739B/xx
Priority to CH2173A priority patent/CH549012A/fr
Priority to GB31173A priority patent/GB1346163A/en
Priority to SE7300133A priority patent/SE395003B/xx
Priority to DE19732300519 priority patent/DE2300519C3/de
Priority to LU66795A priority patent/LU66795A1/xx
Priority to ES410470A priority patent/ES410470A2/es
Priority to AU50889/73A priority patent/AU466588B2/en
Priority to NL7300432A priority patent/NL163513C/xx
Priority to JP713173A priority patent/JPS4986369A/ja
Priority to IT6723573A priority patent/IT1055524B/it
Priority to CA164,402*7A priority patent/CA945158A/en
Priority to SU1886669A priority patent/SU504488A3/ru
Publication of FR2208650A2 publication Critical patent/FR2208650A2/fr
Priority to JP14689574A priority patent/JPS50140446A/ja
Application granted granted Critical
Publication of FR2208650B2 publication Critical patent/FR2208650B2/fr
Priority to JP8156480A priority patent/JPS5618977A/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
FR7242867A 1972-12-01 1972-12-01 4'-aminomethyl-spiro(dibenzo(a,d)cycloheptadi(or tri) - ene-5,2' -(1,3)dioxolan)- antidepressants,analgesics,antiinflammatory Granted FR2208650A2 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
BE793611D BE793611A (fr) 1972-12-01 Nouveaux derives de l'aminomethyl-4'spiro (dibenzo (a-d) cycloheptadi- (ou tri-) ene-5:2'-dioxolane (1',3')), leur procede de preparation et leur application en therapeutique
FR7242867A FR2208650A2 (en) 1972-12-01 1972-12-01 4'-aminomethyl-spiro(dibenzo(a,d)cycloheptadi(or tri) - ene-5,2' -(1,3)dioxolan)- antidepressants,analgesics,antiinflammatory
ZA730009A ZA739B (en) 1972-12-01 1973-01-02 New derivatives of 4'-aminomethyl spiro(dibenzo(a-d)cycloheptadi-(or tri-)ene-5:2'-dioxolane (1',3') their method of preparation and their therapeutic application
CH2173A CH549012A (fr) 1972-12-01 1973-01-03 Procede de preparation de nouveaux derives de l'aminomethyl-4' spiro (dibenzo (a-d) cycloheptadi- (ou tri-) ene5 : 2' -dioxolane (1',3')).
GB31173A GB1346163A (en) 1972-12-01 1973-01-03 Alkyl derivatives of 3-aminomethyl spiro -dibenzo-a-d- cycloheptadi-or tri-ene 5-2- dioxolane 1,3- their method of preparation and their therapeutic application
SE7300133A SE395003B (sv) 1972-12-01 1973-01-04 Sett att framstella derivat av 4' - aminometyl - spiro (dibenso (a,d) - cyklohepta -di-(eller-tri) en 5:2'-dioxolan (1',3)) med farmakologiska egenskaper
LU66795A LU66795A1 (cs) 1972-12-01 1973-01-05
DE19732300519 DE2300519C3 (de) 1972-12-01 1973-01-05 4'-Aminomethyl-spiro-[dibenzo (a,d) cycloheptadi-(oder-tri) en-5,2'-dioxolan d'3')] - Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
ES410470A ES410470A2 (es) 1972-12-01 1973-01-09 Procedimiento de preparacion de derivados de aminometil-4'-espiro (dibenzo(a-d)cicloheptadi-(otri)eno-5:2'-dioxolano- (1',3')).
AU50889/73A AU466588B2 (en) 1972-12-01 1973-01-09 Alkyl derivatives of 4'-aminomethyl spiro [dibenzo (a-d) cycloheptadi-(or tri-) ene-5: 2' - dioxolane (1'-3'], their method of preparation and their therapeutic application
NL7300432A NL163513C (nl) 1972-12-01 1973-01-11 Werkwijze voor de bereiding van een geneesmiddel op basis van 4'-aminomethyl-spiroÿ5,2'-dibenzo(a,d) cycloheptadi-(of tri)-een-1'3'-dioxolanÿ verbindingen, het gevormde geneesmiddel, alsmede werkwijze voor de bereiding van de hiervoor geschikte 4'-aminomethyl- -spiroÿ5,2'-dibenzo(a,d)cycloheptadi-(of tri)-een-1'3'- -dioxolanÿverbindingen.
JP713173A JPS4986369A (cs) 1972-12-01 1973-01-17
IT6723573A IT1055524B (it) 1972-12-01 1973-02-05 Derivati originali dell aminometil 4 spiro dibenzo a cicloeptadio tri ene 5,2 diossolano 1,3,loro procedimento di preparazione e loro applicazione in terapia
CA164,402*7A CA945158A (en) 1972-12-01 1973-02-21 Derives de l'aminomethyl-4' spiro (dibenzo (a-d) cycloheptadi- (ou tri-) ene-5 : 2'-dioxolane (1',3')), leur procede de preparation et leur application en therapeutique
SU1886669A SU504488A3 (ru) 1972-12-01 1973-02-27 Способ получени производных спиро (дибензо (а-д) циклогептади(или три)-ен-5:2"-(4"-аминометилдиоксолана-1",3"))
JP14689574A JPS50140446A (cs) 1972-12-01 1974-12-23
JP8156480A JPS5618977A (en) 1972-12-01 1980-06-18 Manufacture of 4**aminomethylspiro*dibenzo*aa d*cycloheptadi*or tri*enee5 2**dioxolanee *1**3** derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7242867A FR2208650A2 (en) 1972-12-01 1972-12-01 4'-aminomethyl-spiro(dibenzo(a,d)cycloheptadi(or tri) - ene-5,2' -(1,3)dioxolan)- antidepressants,analgesics,antiinflammatory

Publications (2)

Publication Number Publication Date
FR2208650A2 true FR2208650A2 (en) 1974-06-28
FR2208650B2 FR2208650B2 (cs) 1975-11-28

Family

ID=9108086

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7242867A Granted FR2208650A2 (en) 1972-12-01 1972-12-01 4'-aminomethyl-spiro(dibenzo(a,d)cycloheptadi(or tri) - ene-5,2' -(1,3)dioxolan)- antidepressants,analgesics,antiinflammatory

Country Status (4)

Country Link
JP (1) JPS5618977A (cs)
AU (1) AU466588B2 (cs)
FR (1) FR2208650A2 (cs)
ZA (1) ZA739B (cs)

Also Published As

Publication number Publication date
ZA739B (en) 1973-09-26
AU466588B2 (en) 1975-10-30
AU5088973A (en) 1974-07-11
JPS5618977A (en) 1981-02-23
FR2208650B2 (cs) 1975-11-28

Similar Documents

Publication Publication Date Title
AU507427B2 (en) Subsea drilling'production station
IT8821100A0 (it) Macchina perfezionata per laproduzione di granita.
AU511709B2 (en) Track maintenance machine
DE3878340D1 (de) Kristalliner l-carnosin-zink-komplex und dessen herstellung.
BE857493A (fr) Procede d'obtention de souches bacteriennes
GB1549447A (en) Process for the production of 4,4'-isopropylidene-bis-(2,6-dibromophenol)
ZA793739B (en) New piperidine compounds,the process for their preparation and their use as stabilisers for synthetic polymers
FI882495A7 (fi) Anordning foer avspolning av tillsammans med ett spolband i fjaellform pao en spolkaerna uppspolade trycksaker.
DE69107351D1 (de) Masse zum Herstellen von Beschichtungsfilmen.
ES456243A1 (es) Un procedimiento de preparacion de compuestos de aminoalcoxi4-(2h)-piranona-2, sustituidos en posicion 3 y condensados en posicion 5,6.
PL241142A1 (en) Process for preparing novel antibiotic complex a 41030 as well as its agents a,b,c,d,e,f or g and their pharmaceutically acceptable salts
AU2232177A (en) Track tamping machine
ZA774887B (en) New process for the manufacture of 5-amino-1,2,3,-thiadiazole
FR2208652A2 (en) 4'-aminomethyl-spiro(dibenzo(a,d)cycloheptadi(or tri) - ene-5,2' -(1,3)dioxolan)- antidepressants,analgesics,antiinflammatory
FR2208650A2 (en) 4'-aminomethyl-spiro(dibenzo(a,d)cycloheptadi(or tri) - ene-5,2' -(1,3)dioxolan)- antidepressants,analgesics,antiinflammatory
IE45901L (en) Pyridine derivatives
IE790950L (en) Pyridopyrimidones plastics web with a three-dimension microstructure
IE43717L (en) Alkylsulphonylamino phenyl cephalosporins.
PL196355A1 (pl) Sposob mikrobiologicznego wytwarzania mieszaniny androstadieno-1,4-dionu-3,17 i androsteno-4-dionu-3,17
JPS5297934A (en) N#-arylsulfonyl-l-argininamides and their salts acceptable as medicine s
JPS52106844A (en) 3-cyanomethylcyclopentanone derivatives
IE38320L (en) Nor-morphines and nor-codeines
JPS51151968A (en) Suspended type vehicle
NZ184320A (en) Neoviridogriseins 1,iiandiii from the culture of streptomyces sp' atcc 31289
ES456283A1 (es) Un procedimiento para la obetencion de 2,5-dimetil-benzo (b)tieno (2,3-f) morfano.